Cargando…

HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma

BACKGROUND: A key feature of clear cell renal cell carcinoma (ccRCC) is the inactivation of the von Hippel-Lindau tumour suppressor protein (pVHL) that leads to the activation of hypoxia-inducible factor (HIF) pathway also in well-oxygenated conditions. Important regulator of HIF-α, prolyl hydroxyla...

Descripción completa

Detalles Bibliográficos
Autores principales: Miikkulainen, Petra, Högel, Heidi, Rantanen, Krista, Suomi, Tomi, Kouvonen, Petri, Elo, Laura L., Jaakkola, Panu M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496173/
https://www.ncbi.nlm.nih.gov/pubmed/28680592
http://dx.doi.org/10.1186/s40170-017-0167-y
_version_ 1783247918269988864
author Miikkulainen, Petra
Högel, Heidi
Rantanen, Krista
Suomi, Tomi
Kouvonen, Petri
Elo, Laura L.
Jaakkola, Panu M.
author_facet Miikkulainen, Petra
Högel, Heidi
Rantanen, Krista
Suomi, Tomi
Kouvonen, Petri
Elo, Laura L.
Jaakkola, Panu M.
author_sort Miikkulainen, Petra
collection PubMed
description BACKGROUND: A key feature of clear cell renal cell carcinoma (ccRCC) is the inactivation of the von Hippel-Lindau tumour suppressor protein (pVHL) that leads to the activation of hypoxia-inducible factor (HIF) pathway also in well-oxygenated conditions. Important regulator of HIF-α, prolyl hydroxylase PHD3, is expressed in high amounts in ccRCC. Although several functions and downstream targets for PHD3 in cancer have been suggested, the role of elevated PHD3 expression in ccRCC is not clear. METHODS: To gain insight into the functions of high PHD3 expression in ccRCC, we used PHD3 knockdown by siRNA in 786-O cells under normoxic and hypoxic conditions and performed discovery mass spectrometry (LC-MS/MS) of the purified peptide samples. The LC-MS/MS results were analysed by label-free quantification of proteome data using a peptide-level expression-change averaging procedure and subsequent gene ontology enrichment analysis. RESULTS: Our data reveals an intriguingly widespread effect of PHD3 knockdown with 91 significantly regulated proteins. Under hypoxia, the response to PHD3 silencing was wider than under normoxia illustrated by both the number of regulated proteins and by the range of protein expression levels. The main cellular functions regulated by PHD3 expression were glucose metabolism, protein translation and messenger RNA (mRNA) processing. PHD3 silencing led to downregulation of most glycolytic enzymes from glucose transport to lactate production supported by the reduction in extracellular acidification and lactate production and increase in cellular oxygen consumption rate. Moreover, upregulation of mRNA processing-related proteins and alteration in a number of ribosomal proteins was seen as a response to PHD3 silencing. Further studies on upstream effectors of the translational machinery revealed a possible role for PHD3 in regulation of mTOR pathway signalling. CONCLUSIONS: Our findings suggest crucial involvement of PHD3 in the maintenance of key cellular functions including glycolysis and protein synthesis in ccRCC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40170-017-0167-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5496173
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54961732017-07-05 HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma Miikkulainen, Petra Högel, Heidi Rantanen, Krista Suomi, Tomi Kouvonen, Petri Elo, Laura L. Jaakkola, Panu M. Cancer Metab Research BACKGROUND: A key feature of clear cell renal cell carcinoma (ccRCC) is the inactivation of the von Hippel-Lindau tumour suppressor protein (pVHL) that leads to the activation of hypoxia-inducible factor (HIF) pathway also in well-oxygenated conditions. Important regulator of HIF-α, prolyl hydroxylase PHD3, is expressed in high amounts in ccRCC. Although several functions and downstream targets for PHD3 in cancer have been suggested, the role of elevated PHD3 expression in ccRCC is not clear. METHODS: To gain insight into the functions of high PHD3 expression in ccRCC, we used PHD3 knockdown by siRNA in 786-O cells under normoxic and hypoxic conditions and performed discovery mass spectrometry (LC-MS/MS) of the purified peptide samples. The LC-MS/MS results were analysed by label-free quantification of proteome data using a peptide-level expression-change averaging procedure and subsequent gene ontology enrichment analysis. RESULTS: Our data reveals an intriguingly widespread effect of PHD3 knockdown with 91 significantly regulated proteins. Under hypoxia, the response to PHD3 silencing was wider than under normoxia illustrated by both the number of regulated proteins and by the range of protein expression levels. The main cellular functions regulated by PHD3 expression were glucose metabolism, protein translation and messenger RNA (mRNA) processing. PHD3 silencing led to downregulation of most glycolytic enzymes from glucose transport to lactate production supported by the reduction in extracellular acidification and lactate production and increase in cellular oxygen consumption rate. Moreover, upregulation of mRNA processing-related proteins and alteration in a number of ribosomal proteins was seen as a response to PHD3 silencing. Further studies on upstream effectors of the translational machinery revealed a possible role for PHD3 in regulation of mTOR pathway signalling. CONCLUSIONS: Our findings suggest crucial involvement of PHD3 in the maintenance of key cellular functions including glycolysis and protein synthesis in ccRCC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40170-017-0167-y) contains supplementary material, which is available to authorized users. BioMed Central 2017-07-04 /pmc/articles/PMC5496173/ /pubmed/28680592 http://dx.doi.org/10.1186/s40170-017-0167-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Miikkulainen, Petra
Högel, Heidi
Rantanen, Krista
Suomi, Tomi
Kouvonen, Petri
Elo, Laura L.
Jaakkola, Panu M.
HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma
title HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma
title_full HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma
title_fullStr HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma
title_full_unstemmed HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma
title_short HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma
title_sort hif prolyl hydroxylase phd3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496173/
https://www.ncbi.nlm.nih.gov/pubmed/28680592
http://dx.doi.org/10.1186/s40170-017-0167-y
work_keys_str_mv AT miikkulainenpetra hifprolylhydroxylasephd3regulatestranslationalmachineryandglucosemetabolisminclearcellrenalcellcarcinoma
AT hogelheidi hifprolylhydroxylasephd3regulatestranslationalmachineryandglucosemetabolisminclearcellrenalcellcarcinoma
AT rantanenkrista hifprolylhydroxylasephd3regulatestranslationalmachineryandglucosemetabolisminclearcellrenalcellcarcinoma
AT suomitomi hifprolylhydroxylasephd3regulatestranslationalmachineryandglucosemetabolisminclearcellrenalcellcarcinoma
AT kouvonenpetri hifprolylhydroxylasephd3regulatestranslationalmachineryandglucosemetabolisminclearcellrenalcellcarcinoma
AT elolaural hifprolylhydroxylasephd3regulatestranslationalmachineryandglucosemetabolisminclearcellrenalcellcarcinoma
AT jaakkolapanum hifprolylhydroxylasephd3regulatestranslationalmachineryandglucosemetabolisminclearcellrenalcellcarcinoma